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Breast cancer is one of the main life-threatening diseases that a woman may have to 
face during her lifetime. This study was proposed in order to investigate the anti-
cancer effects of the active ingredients of Nigella sativa crude extract, 
Thymoquinone (TQ), and Linoleic Acid (LA) on breast cancer MCF-7 and MDA-
MB-231 cell lines.  According to study design of this research, the study was 
performed in two parts respectively:  
 
1. Extraction and Identification of Nigella sativa composition 
The main objective of this part of the present study was to compare the extract and 
oil composition of Iranian and Indian Nigella sativa L. extracted, using Super 
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Critical Fluid Extraction (SFE) and solvent extraction. In this study, Gas 
Chromatography (GC) equipped with Mass Spectrophotometer (MS) detector was 
employed for qualitative analysis of the essential oil composition of the samples. The 
results indicated that the main fatty acids identified in the essential oils and extracted 
by using SFE and solvent extraction were linoleic acid (22.4-61.85) and oleic acid 
(1.64-18.97). As shown in results, thymoquinone (0.72-21.03) was found to be the 
major volatile compound in the extracted Nigella sativa oil. The oil extraction 
efficiency obtained from SFE was shown to be significantly higher than that 
achieved by solvent extraction technique, qualitatively and quantitatively. The 
present study showed that SFE can be used as a more efficient technique for 
extraction of Nigella sativa L. seed oil compared with solvent extraction technique. 
 
2. Cell line and Culture. Cell lines were maintained in DMEM supplemented with 
10% FBS, penicillin (100 µ/ml), and streptomycin (100 µg/ml) in a humidified 
atmosphere of 5% CO2 at 37 °C. The cytotoxic and apoptotic effects were 
determined by the MTS assay. The results of MTS assay were supported by flow 
cytometry (Cell cycle analysis). Also morphological studies using phase contrast 
were performed by inverted microscope on MCF-7 and MDA-MB-231 cell lines. All 
experiments were performed for 24, 48, and 72 hours of treatments. The results 
showed the cytotoxic effect of linoleic acid on the breast cancer cell lines that can be 
posed as an anticancer effect of linoleic acid. According to our findings, when the 
concentration of linoleic acid is getting increased, compared with the concentrations 
currently being reported, it shows anticancer effects. Thymoquinone has a great 
significant cytotoxic and apoptotic effects on cells. Also the oils of Iranian and 
Indian samples were shown cytotoxic effect on both of cell lines. The cytotoxic 
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effect was observed in lower concentrations on MCF-7 to compare with MDA-MB-
231. In general, MCF-7 was more sensitive compared with MDA-MB-231. In 
conclusion, it can be mentioned that linoleic acid and thymoquinone as two major 
components of oil of Nigella sativa have shown strong cytotoxic and apoptotic 
effects on MDA-MB-231 and MCF-7 breast cancer cell lines. Also the crude extract 
oil showed inhibiting and apoptotic effects on cancer cells in higher concentration 
compared with the linoleic acid and thymoquinone. 
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Kanser payudara merupakan salah satu penyakit pengancam nyawa yang mungkin 
dihidapi oleh wanita semasa hayat mereka. Kajian ini telah dijalankan untuk 
mengesan kesan anti kanser bahan aktif Jintan Hitam (Nigella sativa .L), terhadap sel 
kanser payudara MCF-7 dan MDA-MB-231.  Kajian ini telah dijalankan dalam dua 
peringkat seperti berikut:  
1. Pengekstrakan dan penentuan komposisi utama minyak mentah 
Nigella sativa : 
Objektif utama  kajian pada peringkat ini adalah untuk membandingkan komposisi 
minyak Jintan Hitam dari dari Iran dan India dengan menggunakan kaedah Super 
Critical Fluid Extraction (SFE) dan ekstraksi pelarut (Solvent Extraction). Dalam 
kajian ini, Gas Chromatography (GC) yang dilengkapi dengan pengesan Mass 
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Spectrophotometer (MS) di gunakan  untuk analisis kualitatif bagi mengecam 
komposisi minyak utama sampel-sampel Nigella sativa. Keputusan kajian 
menunjukkan kandungan asid lemak utama dalam  minyak dikenalpasti dengan 
menggunakan kaedah SFE dan ekstraksi pelarut adalah asid linoleik (22.4 - 61.85%) 
dan asid Oleik (1.64 - 18.97%).  Keputusan juga menunjukkan thymoquinone (0.72 - 
21.03%) adalah kompaun utama dalam minyak mudah meruap dengan kadar 
tertinggi yang di kesan dalam minyak mentah Nigella sativa L. Kandungan ekstrak 
minyak yang diperolehi melalui kaedah dari SFE menunjukkan kadar yang lebih 
tinggi berbanding ekstrak yang di perolehi melalui kaedah ekstraksi pelarut secara 
kualitatif dan kuantitatif. Kajian ini menunjukkan kaedah SFE boleh digunakan 
sebagai satu teknik lebih efisien untuk pengekstrakan pati minyak Nigella sativa L 
berbanding dengan teknik ekstraksi pelarut (Solvent Extraction Technique). 
 
2. Sel  kanser dan kultur: Sel kanser payudara jenis MCF-7 dan MDA-MB-231 di 
eram dan dipertahankan dalam larutan DMEM yang ditambahkan 10% FBS, 
penisilin (100 µ/ml), dan ubat antibiotik  streptomycin (100 µg / ml) dalam 
persekitaran yang lembab dengan  5%  gas karbon dioksida (CO2) pada suhu  37 °C. 
Kesan-kesan sitotoksik dan kematian sel (apoptotic) telah dikenalpasti melalui 
cerakin MTS.  Keputusan bagi cerakinan MTS pula telah disokong oleh kaedah 
sitometri aliran (analisis kitaran sel).  Kajian ini juga di lengkapkan dengan 
pengukuran moforlogi sel dengan menggunakan mikroskop arca terbalik berfasa 
kontras keatas sel kanser payudara MCF-7 dan MDA-MB-231. Semua ujikaji 
dijalankan selepas 24, 48, dan 72 jam rawatan dengan asid linoleik, asid oleik dan 
thymoquinone. Keputusan kajian menunjukkan terdapat kesan sitotoksik bagi asid 
linoleik pada sel kanser payudara yang boleh memberi kesan sebagai antikanser.  
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Berdasarkan keputusan kajian juga, apabila kepekatan asid linoleik bertambah, 
berbanding dengan laporan hasil kajian lalu, didapati wujud kesan anti kanser. 
Thymoquinone pula didapati mempunyai satu kesan yang siqnifikan dalam 
menghalang pertumbuhan sel-sel kanser payudara. Minyak mentah Nigella sativa. 
dari sampel-sampel dari Iran dan India juga telah menunjukkan kesan sitotoksik pada 
kedua-dua jenis sel kanser payudara.  Kesan sitotoksik pada sel kanser MCF-7 telah 
dapat diperhatikan dalam kepekatan asid linoleik yang lebih rendah berbanding 
dengan sel MDA-MB-231. Secara umum kajian ini mendapati sel kanser payudara 
MCF-7 adalah lebih peka terhadap kesan sitotoksik asid linoleik dan thymoquinone  
berbanding sel kanser payudara MDA-MB-231.  Sebagai kesimpulan, asid  linoleik  
dan thymoquinone sebagai dua komponen utama minyak pati Jintan Hitam (Nigella 
sativa) telah menunjukkan dengan jelas kesan sitotoksik dan kesan-kesan kematian 
sel (apoptotic) terhadap sel kanser payudara MDA-MB-231 dan MCF-7. Selain itu, 
kajian juga mendapati ekstrak minyak mentah Nigella sativa dapat menghalang 
pertumbuhan sel-sel kanser payudara dan menunjukkan kesan kematian sel kanser 
(apptotic) dalam kepekatan tinggi berbanding dengan asid linoleik dan 
thymoquinone.  
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CHAPTER    1 
 
INTRODUCTION 
1. Introduction 
Cancer is one of the major causes of death worldwide. It is estimated that 12.8% of 
the world population die due to cancer. In the year 2000, 5.3 million men and 4.7 
million women developed a malignant tumor and 6.2 million died from the disease. 
The number of new cases is expected to grow by 50% over the next 20 years to reach 
15 million by 2020 and there were 1,050,346 cases reported with 372,969 deaths 
from breast cancer worldwide (Stewart, 2008).Worldwide, breast cancer is the most 
prevalent cancer in women. Breast cancer is one of the main life-threatening diseases 
that a woman may have to face during her lifetime. More than 1 million women 
worldwide and more than 400,000 women die from it (Stewart, 2003). Breast cancer 
represents 30.4% of all malignancies among women of all ethnic groups in Malaysia 
in 2002, with a cumulative lifetime risk of 1:19 (Lim, G.C.C., 2003). The Age 
Standardized Rate (ASR) of female breast cancer is 52.8 per 100,000 populations 
(Lim, G.C.C., 2003). Latest statistics from the National Cancer Registry (NCR) show 
that lung cancer is the most common cancer experienced by men in the country, 
whilst breast cancer is the top cancer in women. Lung cancer accounts for 13.8 per 
cent of cancer cases among men. For women, breast cancer accounts for 31 per cent 
of cases (Lim, G.C.C., 2003).        
 
Several lifestyle factors such as weight gain, obesity, fat intake, and level of physical 
activity are associated with breast cancer risk. Overweight women are most 
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commonly observed to be at increased risk of postmenopausal breast cancer and at 
reduced risk of premenopausal breast cancer. Obesity and a high intake of meat, 
dairy products, fat, and alcohol may increase risk and a high intake of fiber, fruits, 
vegetables, anti-oxidants, and phytoestrogens may reduce risk (Farah & Begum, 
2003). 
2. Phytomedicine 
Plant products have been used to cure and prevent diseases through history. Natural 
compounds in plants, fungi, and bacteria have provided lead structures that have 
been used to design and plan new drugs in the drug development process. The 
increasing incidence of breast neoplasia reported over the last few decades has led to 
development of new anticancer drugs, drug combinations, and chemotherapy 
strategies by scientific exploration of enormous pool of synthetic, biological, and 
natural products . In light of the continuing needs for effective anti-cancer agents, 
and the association of fruits and vegetables consumption with reduced cancer risk, 
edible plants are increasingly being considered as sources of anticancer drugs. There 
is a large amount of scientific evidence showing that medicinal plants constitute the 
main source of new pharmaceuticals and healthcare products, including medications 
for ethno-veterinary medicine. Recently, cancer chemoprevention with strategies 
using medicinal herbs has been regarded as one of the most visible fields for cancer 
control. Currently, researches are focused on plant-derived anti-tumor drugs, 
antibiotics, and drugs active against tropical diseases, contraceptives drugs, anti-
inflammatory drugs, kidney protectors, and drug for psychiatric use. Epidemiological 
studies suggested that antioxidant supplements might reduce the risk of breast cancer 
recurrence or breast cancer-related mortality, and consuming food and beverages rich 
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in poly-phenols (e.g., catechins, flavones, and antocyanines) is associated with a 
lower incidence of cancers. Experimental investigations demonstrated that many 
naturally occurring agents and plant extracts have shown antioxidant and anticancer 
potential in a variety of bioassay systems and animal models, having relevance to 
human disease (Aziz et al., 2003). Nigella sativa, an oriental spice, has long been 
used as a natural medicine for treatment of many acute as well as chronic conditions. 
It has been used in the treatment of diabetes, hypertension, and dermatological 
conditions (Farah & Begum, 2003). TQ is the bioactive constituent of the volatile oil 
of black seed, which has shown promising anti-cancer effects on animal models. 
Moreover, its combination with clinically used anticancer drugs has led to 
improvements in their therapeutic index and prevents non-tumor tissues from 
sustaining chemotherapy-induced damage (Muhtasib et al., 2006). 
 
This study was proposed in order to investigate the anticancer effects of the active 
ingredients of Nigella sativa crude extracts, thymoquinone, and linoleic acid on 
estrogen-receptor positive (ER+) MCF-7 and estrogen-receptor negative (ER-) 
MDA- MB-231 human breast cancer cell lines. 
 
3. Hypothesis 
3.1. H0 (null hypothesis):  
The presence of thymoquinone, linoleic acid, and seed oil of Nigella sativa seed 
doesn’t have any significant (P < 0.05) anticancer or functional effect on the 
apoptosis or growth of MCF-7 and MDA-MB-231 Cell lines.  
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3.2. HA (alternative hypothesis):  
Thymoquinone, linoleic acid, and seed oil of Nigella sativa have a significant (P < 
0.05) anti-cancer or functional effect on the apoptosis or growth of MCF-7 and 
MDA-MB-231 Cell lines.  
 
3. Research Objectives    
  
3.1. To determine and quantity the compositions of essential oil of Iranian and 
Indian Nigella sativa L seed extracted by different methods; different solvents 
such as methanol, n-hexane, methanol/n-hexane and Supercritical Fluid 
Extractor (SFE).  
 
3.2. To determine the anti-cancer properties of Nigella sativa oil and active 
target components, thymoquinone and linoleic acid on the growth of MCF-7 
and MDA-MB-23 human breast cancer cell lines. 

 
3.3. To determine IC50 of TQ, LA, and Nigella sativa oil on the growth of MCF-
7 and MDA-MB-231human breast cancer cell lines. 
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CHAPTER   2 
Literature Review 
1. Black cumin seed (Nigella sativa L.) 
Nigella sativa L. (Ranunculaceae) with English name Black cumin seed or black 
seed, is traditionally known in Middle Eastern countries as “Habbat al Barakah”-
‘The Blessed Seed’, due to its powerful healing qualities for many ailments. It has 
been used for thousands of years in the Middle East as well as parts of Asia and 
Africa and is now well known in the USA and Europe. The earliest written reference 
to Black seed is found in the book of Jesus in the Old Testament 28:25-27. Ibn Sina, 
Qanun of Medicine, one of the most famous books in the history of medicine, 
recommended Nigella sativa L to stimulate the metabolism and removes 
dispiritedness and lethargy. The Greek Physician Dioskorides used Black seed to 
treat headaches and nasal congestion, toothache, and intestinal parasites. Hypocrates, 
the grandfather of today’s scientific medicine regarded Black seed as a valuable 
remedy in hepatic and digestive disorders. Ayurovedic medicine appreciates its many 
qualities and bitter, warming, stimulant nature. Here it is used for a wide variety of 
diseases like hemorrhoids, hepatitis, fever, diarrhea, cough, and tapeworm, to 
mention only a few of them.  
 
2. Seed oil: 
The oil of Black seed is so beneficial due to its content of over a hundred 
components such as aromatic oils, trace elements, vitamins, and enzymes. It contains 
58% of essential fatty acids including omega 6 and omega 3. These are necessary for 
